Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.49 | 3.89 | 3.07 | 2.57 | 3.03 | 2.31 | 3.43 | 3.15 | 2.27 | 2.48 | 2.62 | 3.43 |
| Expenses | 3.36 | 3.79 | 3.31 | 2.45 | 2.89 | 2.51 | 3.41 | 3.29 | 2.10 | 2.20 | 3.08 | 3.26 |
| Operating Profit | 0.13 | 0.10 | -0.24 | 0.12 | 0.14 | -0.20 | 0.02 | -0.14 | 0.17 | 0.28 | -0.46 | 0.17 |
| OPM % | 3.72% | 2.57% | -7.82% | 4.67% | 4.62% | -8.66% | 0.58% | -4.44% | 7.49% | 11.29% | -17.56% | 4.96% |
| Other Income | 0.04 | 0.06 | 0.11 | 0.08 | 0.08 | 0.16 | 0.11 | 0.17 | 0.11 | 0.04 | 0.10 | 0.07 |
| Interest | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.07 | 0.08 | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 |
| Profit before tax | 0.11 | 0.10 | -0.18 | 0.16 | 0.18 | -0.11 | 0.05 | -0.03 | 0.21 | 0.25 | -0.42 | 0.18 |
| Tax % | 0.00% | 0.00% | 38.89% | 0.00% | 44.44% | 172.73% | -120.00% | -33.33% | 38.10% | 8.00% | -19.05% | 22.22% |
| Net Profit | 0.12 | 0.10 | -0.26 | 0.16 | 0.09 | -0.29 | 0.11 | -0.02 | 0.14 | 0.22 | -0.34 | 0.14 |
| EPS in Rs | 0.02 | 0.02 | -0.05 | 0.03 | 0.02 | -0.05 | 0.02 | -0.00 | 0.03 | 0.04 | -0.06 | 0.03 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.46 | 4.79 | 9.51 | 9.83 | 11.98 | 13.74 | 22.36 | 13.13 | 14.47 | 11.33 | 10.52 | 10.80 |
| Expenses | 3.69 | 4.73 | 8.95 | 9.63 | 11.43 | 13.38 | 21.91 | 13.10 | 14.23 | 11.24 | 10.65 | 10.64 |
| Operating Profit | -0.23 | 0.06 | 0.56 | 0.20 | 0.55 | 0.36 | 0.45 | 0.03 | 0.24 | 0.09 | -0.13 | 0.16 |
| OPM % | -6.65% | 1.25% | 5.89% | 2.03% | 4.59% | 2.62% | 2.01% | 0.23% | 1.66% | 0.79% | -1.24% | 1.48% |
| Other Income | 0.12 | 0.08 | 0.13 | 0.21 | 0.30 | 0.46 | 0.52 | 0.38 | 0.26 | 0.43 | 0.41 | 0.32 |
| Interest | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Depreciation | 0.35 | 0.30 | 0.28 | 0.25 | 0.25 | 0.25 | 0.36 | 0.28 | 0.21 | 0.23 | 0.26 | 0.26 |
| Profit before tax | -0.47 | -0.17 | 0.40 | 0.16 | 0.59 | 0.56 | 0.60 | 0.12 | 0.28 | 0.28 | 0.01 | 0.22 |
| Tax % | -36.17% | -11.76% | 32.50% | 18.75% | 3.39% | 19.64% | 48.33% | 33.33% | 25.00% | 78.57% | 200.00% | |
| Net Profit | -0.31 | -0.15 | 0.27 | 0.14 | 0.57 | 0.44 | 0.31 | 0.08 | 0.20 | 0.07 | 0.01 | 0.16 |
| EPS in Rs | -0.06 | -0.03 | 0.05 | 0.03 | 0.11 | 0.08 | 0.06 | 0.01 | 0.04 | 0.01 | 0.00 | 0.04 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 12% | -5% | -7% | -9% | ||
| Compounded Profit Growth | 7% | -53% | -50% | 245% | ||
| Stock Price CAGR | 16% | -14% | -8% | -24% | ||
| Return on Equity | 3% | 2% | 1% | 0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 |
| Reserves | 0.48 | 0.17 | 0.02 | 0.29 | 0.43 | 1.03 | 1.47 | 1.78 | 1.86 | 1.96 | 2.03 | 2.05 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.60 | 1.04 | 0.74 | 1.43 | 1.14 | 2.14 | 1.92 | 4.52 | 2.02 | 2.56 | 3.48 | 3.56 |
| Total Liabilities | 6.45 | 6.58 | 6.13 | 7.09 | 6.96 | 8.54 | 8.76 | 11.67 | 9.25 | 9.89 | 10.88 | 10.98 |
| Fixed Assets | 2.17 | 1.93 | 1.75 | 1.81 | 1.62 | 1.70 | 1.80 | 1.75 | 1.50 | 1.40 | 1.55 | 1.45 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Other Assets | 4.28 | 4.65 | 4.38 | 5.28 | 5.34 | 6.67 | 6.96 | 9.92 | 7.75 | 8.49 | 9.33 | 9.52 |
| Total Assets | 6.45 | 6.58 | 6.13 | 7.09 | 6.96 | 8.54 | 8.76 | 11.67 | 9.25 | 9.89 | 10.88 | 10.98 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.19 | 0.23 | 0.23 | 0.00 | -0.06 | 1.95 | -1.47 | 1.32 | -0.92 | 1.74 | 0.55 | -0.83 |
| Cash from Investing Activity | -0.14 | 0.01 | -0.12 | 0.00 | -0.05 | -0.50 | -0.19 | -0.23 | -0.03 | -1.88 | -0.96 | 0.85 |
| Cash from Financing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Net Cash Flow | 0.05 | 0.24 | 0.11 | 0.00 | -0.09 | 1.44 | -1.65 | 1.09 | -0.95 | -0.14 | -0.41 | 0.01 |
| Free Cash Flow | -0.18 | 0.11 | 0.11 | 0.00 | -0.11 | 1.45 | -1.66 | 1.08 | -0.95 | 1.63 | 0.16 | -0.99 |
| CFO/OP | -475% | -100% | 383% | 0% | -15% | 356% | -372% | 333% | -2,967% | 796% | 667% | 615% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 183.50 | 132.92 | 84.58 | 54.88 | 33.79 | 31.08 | 44.89 | 53.05 | 64.22 | 57.26 | 77.96 | 72.51 |
| Inventory Days | 170.89 | 297.41 | 179.91 | 102.66 | 125.86 | 99.18 | 145.11 | 104.78 | 147.45 | 86.65 | 152.87 | 220.21 |
| Days Payable | 86.27 | 177.67 | 78.95 | 82.53 | 47.61 | 84.31 | 71.22 | 37.63 | 51.11 | 38.08 | 92.93 | 115.38 |
| Cash Conversion Cycle | 268.12 | 252.65 | 185.54 | 75.01 | 112.04 | 45.95 | 118.78 | 120.21 | 160.55 | 105.84 | 137.90 | 177.34 |
| Working Capital Days | 246.68 | 208.87 | 136.40 | 82.13 | 96.17 | 48.14 | 98.02 | 50.93 | 116.76 | 60.54 | 69.91 | 122.13 |
| ROCE % | -5.71% | -8.08% | -2.93% | 7.42% | 2.79% | 9.82% | 8.61% | 8.72% | 1.81% | 3.98% | 3.12% | 0.27% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 28.74% | 28.74% | 28.74% | 28.74% | 28.74% | 28.74% | 28.74% | 28.74% | 28.74% | 28.74% | 28.74% | 28.74% |
| DIIs | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% |
| Public | 70.87% | 70.86% | 70.86% | 70.87% | 70.86% | 70.87% | 70.87% | 70.86% | 70.88% | 70.88% | 70.88% | 70.87% |
| No. of Shareholders | 33,147 | 33,326 | 33,879 | 33,886 | 36,491 | 39,959 | 41,284 | 41,137 | 40,454 | 39,693 | 39,077 | 38,725 |
Fundamentals
Market Cap₹ 17.4 Cr.
Current Price₹ 3.24
Stock P/E109
Book Value₹ 1.38
ROCE0.27 %
ROE0.13 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)-9%
Compounded Profit Growth (TTM)245%
Standalone figures.
Valuation
Market capRs 17 Cr
Enterprise valueRs 17 Cr
P/E (TTM)105.80x
Price to book2.28x
Price to sales1.57x
EV / EBITDA33.79x
EV / EBIT71.99x
EV / sales1.53x
Earnings yield0.95%
P/E, 3-year average577.27x
P/B, 3-year average2.60x
P/E, 5-year average424.55x
P/B, 5-year average3.22x
Profitability
Operating margin (excl. other income)-1.24%
Operating margin (incl. other income)2.66%
EBITDA margin4.54%
Pre-tax margin2.04%
Net profit margin1.48%
Net margin, latest quarter4.08%
ROE0.14%
ROCE0.27%
ROA0.09%
ROE, 3-year average1.28%
ROCE, 3-year average2.73%
ROA, 3-year average0.95%
ROE, 5-year average1.88%
ROCE, 5-year average3.74%
ROA, 5-year average1.33%
ROIC (approx.)-3.26%
Tax rate200.00%
Other income / net worth5.53%
Growth
Sales growth (latest year)-7.15%
Profit growth (latest year)-85.71%
Sales CAGR, 3 years-7.12%
Sales CAGR, 5 years-5.20%
Profit CAGR, 3 years-50.00%
Profit CAGR, 5 years-53.09%
Sales growth QoQ30.92%
Sales growth YoY (latest quarter)8.89%
Per share
EPS (TTM)Rs 0.03
EPS (latest year)Rs 0.00
EPS (latest quarter)Rs 0.03
EPS, 3-year averageRs 0.02
EPS, 5-year averageRs 0.02
Book value per shareRs 1.38
Sales per shareRs 2.01
Cash flow per shareRs -0.15
Free cash flow per shareRs -0.18
Efficiency
Asset turnover0.96x
Fixed asset turnover7.26x
Inventory turnover1.98x
Inventory days184 days
Debtor days73 days
Debtors turnover5.03x
Creditor days115 days
Cash conversion cycle177 days
Working capital days122 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Net debt / EBITDA-0.76x
Interest coverage23.00x
Owners' fund to total sources67.58%
Cash flow
Cash from Operating Activity (latest year)Rs -1 Cr
Cash from Investing Activity (latest year)Rs 1 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -1 Cr
Cash from ops / profit, 5 years2.78x
Statement figures
Net sales (TTM)Rs 11 Cr
Net sales (latest year)Rs 11 Cr
Sales (latest quarter)Rs 3 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 0 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 6 Cr
Total expenditure (latest year)Rs 11 Cr
Total income (latest year)Rs 11 Cr
Share capitalRs 5 Cr
ReservesRs 2 Cr
Shareholders' fundsRs 7 Cr
Total assetsRs 11 Cr
Net blockRs 1 Cr
InvestmentsRs 0 Cr
ReceivablesRs 2 Cr
InventoryRs 3 Cr
Other liabilitiesRs 4 Cr
Shares outstanding (crore)5.37
Ownership
Promoter holding28.74% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 105.8 is at the 67th percentile of its own 7.4-year range
(median 85.1, low 15.2, high 364.8).
P/B 2.28 is at the 34th percentile (median 2.99).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 530665 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.6% | -2.8% | +1.2 pts |
| 1 month | +3.3% | -6.8% | +10.1 pts |
| 3 months | +3.6% | -7.6% | +11.2 pts |
| 3 years | -21.6% | +14.2% | -35.8 pts |
| 5 years | -54.0% | +27.9% | -81.9 pts |
Red flags
F-score 3 of 8| look | Inventory outrunning sales Inventory grew 29% vs sales -7% in 2026 |
| look | Profit leans on other income Other income was 4100% of pre-tax profit in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹3 Cr +8.9% vs Jun 2025.
Net profit ₹0 Cr +800.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Zenith Health Care Ltd?
Zenith Health Care Ltd (530665) has a market capitalisation of Rs 17.4 Cr. at the 2026-10-01 close.
What is the P/E ratio of Zenith Health Care Ltd?
Zenith Health Care Ltd trades at a P/E of 109 on trailing twelve-month profit, at the 2026-10-01 close.
What were Zenith Health Care Ltd's latest quarterly results?
In the Jun 2026 quarter, Zenith Health Care Ltd sales was Rs 3 Cr (+8.9% vs Jun 2025) and net profit was Rs 0 Cr.